Stavudine-induced pancreatitis followed by lopinavir-ritonavir-induced pancreatitis.
Anand
H
H
Department of Clinical Pharmacy, JSS College of Pharmacy, SS Nagara, Mysore, India.
Parthasarathi
G
G
Ramesh
M
M
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced*; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects*; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects*; D018119:Stavudine / Q000008:administration & dosage / Q000009:adverse effects*
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D018119:Stavudine; D019438:Ritonavir